Results 81 to 90 of about 8,392,421 (384)

REGULATION OF REACTIVE POWER PRODUCED BY DOUBLY FED INDUCTION WIND GENERATORS [PDF]

open access: yes, 2018
Study the methods of providing balance of reactive power by means of the voltage applied to the rotor of doubly fed induction wind ...
IVANOV, Oleksii, LIABAHOVA, Tetiana
core  

Tight-and-Cheap Conic Relaxation for the Optimal Reactive Power Dispatch Problem [PDF]

open access: yesIEEE Transactions on Power Systems, 2018
The optimal reactive power dispatch (ORPD) problem is an alternating current optimal power flow (ACOPF) problem where discrete control devices for regulating the reactive power, such as shunt elements and tap changers, are considered. The ORPD problem is
Christian Bingane   +2 more
semanticscholar   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Additional reactive power control and emergency control of the ±1100 kV UHVDC system with a hierarchical connection mode

open access: yesThe Journal of Engineering, 2019
This paper proposes an additional reactive power control strategy and an emergency control strategy for ±1100 kV ultra-high voltage direct current (UHVDC) system with a hierarchical connection mode, in which the inverter station connect to two AC systems
Yongxin Xiong, Wei Yao, Jinyu Wen
doaj   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

A COMPUTER CALCULATION FOR TENTATIVE ELECTRICAL SYSTEM IMPROVEMENT BY REACTIVE POWER COMPENSATION CONSIDERING SYSTEM UNBALANCED [PDF]

open access: yes, 2013
An improvement of unbalanced distribution system operation is carried out by reactive power compensation. The lagging reactive power demand is compensated by allocating a number of three-phase shunt capacitors.
Agus , Supardi   +2 more
core  

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

PowerModels.jl: An Open-Source Framework for Exploring Power Flow Formulations

open access: yes, 2018
In recent years, the power system research community has seen an explosion of novel methods for formulating and solving power network optimization problems.
Bent, Russell   +4 more
core   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy